Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Net margin, % | ? | -101.0% | -109.0% | -24.1% | -12.4% | 8.45% | 13.5% | |
| Changes by years, y/y, % | +73pp | -8pp | +85pp | +12pp | +21pp | |||
Alnylam Pharmaceuticals. Net margin, %
Alnylam Pharmaceuticals. Net margin, changes, pp
Alnylam Pharmaceuticals (ALNY) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Net margin, % | ? | -9.67% | -8.57% | 20.1% | 17.0% | 17.6% | 13.5% | |
| Changes by years, y/y, % | +4pp | -6pp | +42pp | +31pp | +27pp | |||
| Changes by quarters, q/q, % | +4pp | +1pp | +29pp | -3pp | +1pp | |||